Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
Recruiting now
Conditions studied: Retinopathy of Prematurity (ROP), ROP Examination
In brief
The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascular information has not been adequately investigated for its diagnostic potential. Furthermore, we seek to identify disease features not currently accessible by standard examination methods to better inform clinical decisions.
Key facts
- Study ID
- NCT06612541
- Run by
- Vanderbilt University Medical Center
- People needed
- 90
- Starts
- 2025-02-01
- Expected to finish
- 2030-02-01
- Last updated by the study team
- 2026-08-04
Who can join
Age: 0 and older, up to 1. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Preterm male and female infants born at 24-34 weeks gestational age and weighing \<1500g at birth
You may not qualify if…
- Infants surgically treated for ROP
- Infants with significant health concern that would preclude noninvasive retinal imaging as noted by the primary inpatient team
Where it is running
- Vanderbilt University Medical Center — Nashville, Tennessee, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.